RxDoctor Payments Data

Robert Puchalski, MD

Sleep Medicine · Lugoff, SCNPI 1740215904

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by AstraZeneca at 41.8% of the total. 2025 is the largest year on record at $2,079, 2.5 times the $842 reported in 2019.

$3,969in general payments, 2019–2025

Across 34 payments — averaging $116.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Inspire Medical Systems, Inc.$776
  • Stryker$552
  • Integra Lifesciences Corporation$314
  • Medtronic$245
  • GSK$169
  • plus $254 from 7 others
$10,352in research payments, 2019–2025

Across 17 payments — averaging $608.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$10K

What the payments were for

  • Speaking & faculty fees$1,64041%
  • Travel & lodging$50313%
  • Food & beverage$1,82646%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,969 in reported general payments places this provider in the 75th percentile of 25 sleep medicine providers in South Carolina.

See all sleep medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$654,571
Medicare patients
1,174
Services billed
21,575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate64$885
Montelukast Sodium83$793
Azelastine Hcl26$581
Ipratropium Bromide11$469
CefuroximeCefuroxime Axetil41$348
Omeprazole21$306
Famotidine17$197
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen41$129
Prednisone19$19

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Lugoff

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →